TrialBMC cardiovascular disorders2023

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial.

William Barbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.